Document Detail


Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients.
MedLine Citation:
PMID:  20507951     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND OBJECTIVES: Achieving and maintaining dry-weight appears to be an effective but forgotten strategy in controlling and maintaining normotension among hypertensive patients on hemodialysis.
METHODS: Qualitative review of literature to define dry-weight and its utility in achieving blood pressure control.
RESULTS: The concept of dry-weight has evolved over time and its definition has changed. One such definition defines dry-weight as the lowest tolerated postdialysis weight achieved via gradual change in postdialysis weight at which there are minimal signs or symptoms of hypovolemia or hypervolemia. Although clinical examination does not perform well in detecting latent increase in dry-weight, several technologies such as relative plasma volume monitoring and body impedance analysis are emerging that may help in assessing dry-weight in the future. Sodium restriction is a modifiable risk factor that can lead to better blood pressure (BP) control. However, dietary sodium restriction requires lifestyle modifications that are difficult to implement and even harder to sustain over the long term. Restricting dialysate sodium is a simpler but underexplored strategy that can reduce thirst, limit interdialytic weight gain, and assist the achievement of dry-weight. Achievement of dry-weight can improve interdialytic BP, reduce pulse pressure, and limit hospitalizations.
CONCLUSIONS: Avoiding medication-directed control of BP may enhance the opportunity to probe dry-weight, facilitate removal of volume, and limit the risk for pressure-volume overload, which may be a significant concern leading to myocardial remodeling in the hemodialysis patient. Probing dry-weight among patients with ESRD has the potential to improve dismal cardiovascular outcomes.
Authors:
Rajiv Agarwal; Matthew R Weir
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2010-05-27
Journal Detail:
Title:  Clinical journal of the American Society of Nephrology : CJASN     Volume:  5     ISSN:  1555-905X     ISO Abbreviation:  Clin J Am Soc Nephrol     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-08     Completed Date:  2010-10-26     Revised Date:  2011-08-01    
Medline Journal Info:
Nlm Unique ID:  101271570     Medline TA:  Clin J Am Soc Nephrol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1255-60     Citation Subset:  IM    
Affiliation:
Division of Nephrology, Department of Medicine, Indiana University School of Medicine, and Roudebush VA Medical Center, 1481 West 10th Street, 111N, Indianapolis, IN 46202, USA. ragarwal@iupui.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antihypertensive Agents / adverse effects*
Blood Pressure*
Blood Volume Determination
Body Composition
Body Water / metabolism
Body Weight*
Cardiovascular Diseases / etiology,  physiopathology,  prevention & control*
Diet, Sodium-Restricted
Electric Impedance
Hemodialysis Solutions / chemistry,  therapeutic use*
Humans
Hypertension / complications,  physiopathology,  therapy*
Kidney Failure, Chronic / complications,  physiopathology,  therapy*
Male
Plasma Volume
Predictive Value of Tests
Renal Dialysis*
Terminology as Topic
Water-Electrolyte Balance
Grant Support
ID/Acronym/Agency:
2 R01-DK062030-06/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Hemodialysis Solutions
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Survival benefits with vitamin D receptor activation: new insights since 2003.
Next Document:  N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis pa...